Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829461 · ClinicalTrials.gov registry record · NA
Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy
A NA study of Cystoscopy and Ureteral Stent, sponsored by Ambu.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 3
- Study locations
NCT04829461: Completed NA study of Cystoscopy and Ureteral Stent, sponsored by Ambu.
NCT04829461 is a NA study of Cystoscopy and Ureteral Stent that has completed, run by Ambu. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829461, a NA study of Cystoscopy and Ureteral Stent, has completed, sponsored by Ambu.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the use of the single-use Ambu® aScope™ 4 Cysto for removal of ureteral stents as compared to routine flexible reusable cystoscopes.
Primary Outcome
The success rate of the Ambu® aScope™ 4 Cysto and the Ambu® aView™ 2 Advance for stent removal procedures performed in the outpatient setting. Primary outcome is number of participants with successful stent removal with the Ambu® aScope™ 4 Cysto and the Ambu® aView™ 2 Advance compared to the Standard of Care.
Conditions Studied
Interventions
- DEVICE Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removal
- DEVICE Standard of care reusable cystoscope used for stent removal
Study Locations (3)
Pennsylvania
- The Pennsylvania State University and The Milton S. Hershey Medical Center - Hershey
Texas
- University of Texas Southwestern Medical Center - Dallas
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
What the finished NCT04829461 record still lists
NCT04829461 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Cystoscopy appearing as the primary indexed condition, and to 2 interventions - of which Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removal is the first listed.
NCT04829461 reports a single indexed study location in Pennsylvania, Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04829461 about?
NCT04829461 is a clinical study titled "Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy". The purpose of this study is to evaluate the use of the single-use Ambu® aScope™ 4 Cysto for removal of ureteral stents as compared to routine flexible reusable cystoscopes.
What is the current status of trial NCT04829461?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2021-04-27. Estimated completion is 2022-07-20.
What conditions does trial NCT04829461 study?
This clinical trial studies the following conditions: Cystoscopy, Ureteral Stent.
What interventions are being tested in trial NCT04829461?
The interventions under investigation include: Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removal (DEVICE), Standard of care reusable cystoscope used for stent removal (DEVICE).
Who is sponsoring clinical trial NCT04829461?
This trial is sponsored by Ambu, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04829461 being conducted?
This trial has 3 study locations across Pennsylvania, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04829461's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI